Open AccessThe therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial
Author(s) -
Jun Wada
Publication year - 2012
Publication title -
international journal of nephrology and renovascular disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.846
H-Index - 27
ISSN - 1178-7058
DOI - 10.2147/ijnrd.s32191
Subject(s) - medicine , furosemide , nephrotic syndrome , creatinine , gastroenterology , excretion , endocrinology , diuretic
In nephrotic syndrome, the combination of furosemide and albumin infusion is a standard regimen to treat systemic edema. The efficacy of synthetic human atrial natriuretic peptide (hANP) for nephrotic syndrome to ameliorate the systemic edema and retain renal functions has not been fully demonstrated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom